Anatomy & Body Systems
Hippocampus and Entorhinal Cortex:
The hippocampus and entorhinal cortex are affected earliest and most severely in Alzheimer's disease. These structures are critical for:
- Formation of new memories
- Spatial navigation
- Consolidation of short-term to long-term memory
- Contextual memory (remembering where and when events occurred)
Damage to these areas explains why memory loss, particularly for recent events, is typically the first and most prominent symptom.
Temporal Parietal Network:
As the disease progresses, it spreads to:
- Lateral temporal cortex (affects language and word-finding)
- Posterior cingulate (affects attention and executive function)
- Parietal lobes (affects spatial abilities)
Prefrontal Cortex:
Involvement of the prefrontal cortex leads to:
- Executive function deficits (planning, reasoning, judgment)
- Behavioral changes
- Difficulty with complex tasks
Default Mode Network:
This network, active during rest and self-referential thinking, is particularly vulnerable in Alzheimer's, affecting self-awareness and mind-wandering.
Amyloid Cascade Hypothesis:
The predominant theory suggests that accumulation of amyloid-beta protein initiates a cascade leading to:
- Amyloid plaque formation
- Synaptic dysfunction
- Tau pathology spread
- Neuronal loss
- Brain atrophy
Tau Propagation:
Tau pathology spreads in a predictable pattern:
- Entorhinal cortex
- Hippocampus
- Limbic system
- Isocortex
While Alzheimer's is primarily a brain disorder, it affects and is affected by:
Cardiovascular System:
- Vascular disease increases risk
- Cerebral blood flow reduction
- Cardiovascular health affects progression
Metabolic System:
- Diabetes increases risk
- Insulin resistance may affect brain
- Metabolic syndrome connection
Inflammatory System:
- Chronic neuroinflammation
- Microglial activation
- Inflammatory markers elevated
Types & Classifications
Early-Onset Alzheimer's (EOAD):
- Onset before age 65
- Represents 5-10% of cases
- Often rapid progression
- More likely to have genetic mutations (APP, PSEN1, PSEN2)
- Often presents with non-memory symptoms initially
- More likely to have atypical presentations
Late-Onset Alzheimer's (LOAD):
- Onset after age 65
- Most common form (90-95% of cases)
- APOE4 is major risk factor
- More typical memory presentation
- Slower progression usually
Typical Amnestic Presentation:
- Prominent memory loss (especially recent memories)
- Gradual onset
- Most common pattern
Atypical Presentations:
- Posterior Cortical Atrophy: Visual/spatial difficulties first
- Language Variant (Primary Progressive Aphasia): Language difficulties first
- Behavioral Variant Frontotemporal: Personality/behavior changes first
- Logopenic Variant: Word-finding difficulties prominent
Mild Alzheimer's:
- Independent functioning
- May still work
- Memory lapses noticeable
- Difficulty with complex tasks
Moderate Alzheimer's:
- Requires some assistance
- Significant memory impairment
- Personality changes
- Daily living activities affected
Severe Alzheimer's:
- Total dependence
- Loss of verbal communication
- Mobility problems
- Total care required
Causes & Root Factors
Deterministic Genes (Early-Onset):
- APP (Amyloid Precursor Protein): Chromosome 21
- PSEN1 (Presenilin 1): Chromosome 14 - most common
- PSEN2 (Presenilin 2): Chromosome 1 - rarest
These mutations cause autosomal dominant Alzheimer's with near 100% penetrance.
Risk Genes (Late-Onset):
- APOE4: Strongest risk factor, 3-4x risk with one copy, 10-15x with two copies
- CLU (Clusterin): Moderate risk
- PICALM: Moderate risk
- CR1: Moderate risk
Amyloid Processing:
- Abnormal APP metabolism
- Increased production or decreased clearance
- Toxic oligomer formation
- Plaque deposition
Tau Pathology:
- Hyperphosphorylation
- Misfolding and aggregation
- Neurofibrillary tangle formation
- Spreading along neural networks
Neurodegeneration:
- Synaptic loss
- Neuronal death
- Neuroinflammation
- Oxidative stress
- Mitochondrial dysfunction
Risk-Increasing Factors:
- Cardiovascular disease
- Diabetes
- Smoking
- Head trauma
- Depression
- Low education
- Sleep disturbances
Potentially Protective Factors:
- Physical exercise
- Cognitive stimulation
- Social engagement
- Mediterranean diet
- Adequate sleep
Risk Factors
Age: The single greatest risk factor. Prevalence doubles every 5 years after 65.
Genetics: Family history increases risk. Specific genes cause early-onset forms.
Sex: Women are at slightly higher risk, possibly due to longer lifespan and hormonal factors.
Ethnicity: Higher rates in African Americans and Hispanics compared to Caucasians.
Cardiovascular Health:
- Hypertension
- Heart disease
- High cholesterol
- Stroke history
Lifestyle Factors:
- Physical inactivity
- Smoking
- Excessive alcohol
- Poor diet
Cognitive Reserve:
- Lower education
- Less mental stimulation
- Social isolation
Other Medical Conditions:
- Diabetes
- Depression
- Traumatic brain injury
Signs & Characteristics
Early Signs:
- Forgetting recent conversations or events
- Repeating questions
- Misplacing items
- Forgetting names of new acquaintances
- Difficulty remembering appointments
Progression:
- Older memories affected later
- May confuse past with present
- Eventually all memories affected
Executive Function:
- Difficulty planning or organizing
- Problems with multitasking
- Poor judgment
- Difficulty with problem-solving
Language:
- Word-finding difficulty
- Calling things by wrong names
- Vocabulary decline
- Eventually loss of speech
Visuospatial:
- Getting lost in familiar places
- Difficulty with directions
- Problems judging distances
- Confusion about time and place
| Symptom | Frequency |
|---|---|
| Apathy | 50-70% |
| Depression | 40-50% |
| Anxiety | 30-40% |
| Agitation | 30-40% |
| Sleep Disturbances | 30-40% |
| Wandering | 20-30% |
| Aggression | 15-20% |
| Hallucinations | 10-15% |
Associated Symptoms
| Symptom | Connection | Frequency |
|---|---|---|
| Tremor | May coexist with Parkinson's | 20-30% |
| Seizures | More common in early-onset | 10-15% |
| Gait Disturbance | Later stages | 50-60% |
| Muscle Rigidity | Later stages | 40-50% |
- Cardiovascular Disease: Strong association
- Diabetes: Increases risk and may affect progression
- Osteoporosis: More common in later stages
- Caregiver burnout
- Depression
- Financial strain
- Social isolation
Clinical Assessment
1. Memory Concerns
- What specific memory problems are noticed?
- How long have they been present?
- Are they getting worse?
- What types of things are forgotten?
2. Functional Changes
- Can the person still manage finances?
- Can they cook or manage medications?
- Are they getting lost?
- Do they need help with daily activities?
3. Behavioral Changes
- Personality changes?
- Mood changes?
- Sleep problems?
- Agitation or aggression?
4. Medical History
- Previous strokes or TIAs?
- Heart disease?
- Diabetes or metabolic conditions?
- Head injuries?
5. Family History
- Alzheimer's or dementia in family?
- Other neurological conditions?
Activities of Daily Living:
- Basic ADLs (bathing, dressing, toileting, feeding)
- Instrumental ADLs (cooking, finances, transportation, medications)
Cognitive Testing:
- Mini-Mental State Examination (MMSE)
- Montreal Cognitive Assessment (MoCA)
- Clinical Dementia Rating (CDR)
Diagnostics
Screening Tests:
- MMSE (30 points max, <24 suggests impairment)
- MoCA (30 points max, <26 suggests impairment)
- Mini-Cog
Detailed Neuropsychological Testing:
- Memory assessment
- Executive function testing
- Language testing
- Visuospatial testing
Structural Imaging:
- MRI brain: Assesses atrophy, rules out other causes
- CT brain: Useful if MRI unavailable
Functional Imaging:
- FDG-PET: Shows hypometabolism in Alzheimer's pattern
- Amyloid PET: Shows amyloid plaques (research/clinical use)
Cerebrospinal Fluid:
- Reduced amyloid-beta 42
- Increased total tau
- Increased phosphorylated tau
Blood Tests:
- Emerging amyloid and tau tests
- Used in research and some clinical settings
Laboratory Tests
Routine Tests:
- CBC, CMP
- Thyroid function
- B12 and folate
- HIV, syphilis screening (when indicated)
Differential Diagnosis
Vascular Dementia:
- Stepwise progression
- Stroke history
- Focal neurological signs
- MRI shows vascular changes
Lewy Body Dementia:
- Fluctuating cognition
- Visual hallucinations
- Parkinsonism
- REM sleep behavior disorder
Frontotemporal Dementia:
- Early behavioral changes
- Language problems
- Personality changes
- Less memory loss initially
Mild Cognitive Impairment:
- Objective deficit but functional preserved
- May progress to Alzheimer's
Depression (Pseudodementia):
- Cognitive complaints prominent
- Mood symptoms prominent
- May improve with treatment
Normal Pressure Hydrocephalus:
- Gait disturbance prominent
- Urinary incontinence
- Cognitive decline
Conventional Treatments
Cholinesterase Inhibitors:
- Donepezil (Aricept)
- Rivastigmine (Exelon)
- Galantamine (Razadyne)
For mild to moderate Alzheimer's.
NMDA Receptor Antagonist:
- Memantine (Namenda)
For moderate to severe disease.
Combination Therapy:
- Donepezil + Memantine
Non-Pharmacological Approaches:
- Routine and structure
- Environmental modifications
- Communication strategies
- Activity programming
Pharmacological:
- Antidepressants
- Antipsychotics (caution needed)
- Mood stabilizers
- Sleep medications (caution)
Disease-Modifying Therapies:
- Amyloid-targeting antibodies (lecanemab, donanemab)
- Tau-targeting therapies
- Anti-inflammatory approaches
Integrative Treatments
Constitutional Prescribing:
- Individualized remedy selection
- Focus on neurological support
- Support for cognitive function
- Remedies may include: Baryta carb, Alumina, Conium, Lycopodium
Symptomatic Support:
- Memory support remedies
- Sleep support
- Mood support
Dosha Assessment:
- Evaluation of vata, pitta, kapha
- Neurological vata disorders assessment
- Personalized protocols
Detoxification:
- Gentle panchakarma when appropriate
- Vata-pacifying treatments
Herbal Support:
- Brahmi (Bacopa monnieri)
- Shankhapushpi (Convolvulus pluricaulis)
- Ashwagandha (Withania somnifera)
- Turmeric (Curcuma longa)
- Medhya rasayanas
Dietary Guidance:
- Brain-healthy foods
- Vata-pacifying diet
- Antioxidant-rich foods
Components:
- Reality orientation
- Reminiscence therapy
- Validation therapy
- Skill learning
- Music therapy
- Art therapy
Benefits:
- Maintains mobility
- Reduces behavioral symptoms
- Improves sleep
- Cardiovascular health
Interventions:
- Safe exercise programs
- Balance training
- Functional mobility
Recommendations:
- Mediterranean diet
- Omega-3 fatty acids
- Antioxidants
- B vitamins
- Vitamin D
- Avoiding processed foods
For Patients:
- Counseling
- Reality orientation support
- Validation therapy
For Caregivers:
- Caregiver education
- Support groups
- Stress management
- Respite care coordination
Self Care
Physical Activity:
- Regular moderate exercise
- Walking
- Swimming
- Dancing
Cognitive Stimulation:
- Reading
- Puzzles
- Learning new skills
- Social engagement
Sleep Hygiene:
- Regular sleep schedule
- Calm bedtime routine
- Adequate darkness
- Comfortable temperature
Safety:
- Remove hazards
- Install grab bars
- Use assistive devices
- Consider monitoring systems
Orientation Aids:
- Calendars and clocks
- Labels on doors and drawers
- Photographs of family
- Clear signage
- Speak clearly and simply
- Use short sentences
- Give time to respond
- Use non-verbal communication
- Avoid arguing or correcting
Prevention
Primary Prevention
Cardiovascular Health:
- Control blood pressure
- Manage cholesterol
- Treat heart conditions
- Exercise regularly
Lifestyle:
- Don't smoke
- Limit alcohol
- Exercise regularly
- Maintain healthy weight
Cognitive Reserve:
- Lifelong learning
- Social engagement
- Mental stimulation
Know the Signs:
- Memory changes beyond normal aging
- Difficulty with familiar tasks
- Language problems
- Disorientation
- Poor judgment
When to Seek Evaluation:
- Changes affecting daily life
- Family concerns
- Progressive changes
When to Seek Help
- Memory problems are getting worse
- Difficulty with daily activities
- Personality or behavior changes
- Safety concerns
- Caregiver stress
Comprehensive Assessment:
- Detailed history
- Physical examination
- Cognitive testing
- NLS screening
- Laboratory evaluation
Personalized Plan:
- Individualized treatment approach
- Integrative therapies
- Caregiver support
- Ongoing monitoring
Prognosis
Average Duration:
- 8-10 years from diagnosis
- 4-20 year range
Stage Progression:
- Mild: 2-4 years
- Moderate: 2-10 years
- Severe: 1-3 years
Factors Affecting Prognosis
Positive Factors:
- Younger age at onset
- Higher education
- Good cardiovascular health
- Strong social support
Negative Factors:
- Older age at onset
- Rapid progression
- Behavioral symptoms
- Comorbidities
Goals:
- Maximize function
- Maintain dignity
- Support independence
- Enhance quality of life
- Support caregivers
FAQ
What is the difference between Alzheimer's and dementia?
Dementia is an umbrella term for cognitive decline severe enough to affect daily function. Alzheimer's disease is the most common cause of dementia, accounting for 60-80% of cases.
Some forms are. Early-onset Alzheimer's can be caused by specific gene mutations and is hereditary. Late-onset Alzheimer's has genetic risk factors but is not directly inherited in most cases.
Currently, there is no cure. However, treatments can slow progression, manage symptoms, and improve quality of life.
Progression varies. Average survival after diagnosis is 8-10 years, but can range from 4-20 years.
Yes, about 5-10% of cases are early-onset, occurring before age 65.
Control cardiovascular risk factors, exercise regularly, maintain social engagement, eat a healthy diet, and keep mentally active.
Last Updated: March 9, 2026 Author: Healers Clinic Medical Team